Robert-Jan Lebbink

16PUBLICATIONS
72CO-AUTHORS
Medical infection agents (incl. prions)Cellular nervous systemAdolescent healthAutoimmunitySpeciation and extinction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 06, 2026
Clinically relevant RSV anti-F antibodies exhibit comparable inhibition of syncytium formation despite marked differences in neutralization potency.

|Jul 30, 2025
Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection.

Virginie Girault, Alexey Stukalov, Madalina Elena Carter-Timofte

|Jul 16, 2025
Identification of β4GALNT2 as an anti-hPIV3 factor through genome-wide CRISPR/Cas9 library screening.

Xuesheng Wu, Rutger D Luteijn, Estefanía Lozano-Andrés

|May 25, 2024
m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression.

Lucas W Picavet, Ellen C N van Vroonhoven, Rianne C Scholman

|May 24, 2024
Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.

Tom Cremer, Hanneke Hoelen, Michael L van de Weijer

|Apr 10, 2024
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus.

Annefleur C Langedijk, Bram Vrancken, Robert Jan Lebbink

Pageof 3

Frequent Collaborators

4 joint publications

Emmanuel J H J Wiertz

2 joint publications

Michael L van de Weijer

2 joint publications

Ellen C N van Vroonhoven

2 joint publications

Michiel van der Vlist